Is GHK-Cu legal in Canada?
GHK-Cu is absent from the Drug Product Database as an authorized product. Health Canada has run no safety, efficacy or quality review of it. It is held by Borealis Peptides for in-vitro research and supplied for use in no living subject.
Health Canada status
No Drug Identification Number issued
GHK-Cu is absent from the Drug Product Database as an authorized product. Health Canada has run no safety, efficacy or quality review of it. Borealis Peptides keeps it solely for in-vitro research, provided for use in no living subject.
In Canada a drug authorization shows up as a Drug Identification Number in a publicly open database. Anything lacking one has not cleared a review. On 9 April 2026 Health Canada stated that "Research Use Only" labelling does not make a product legal or exempt from regulatory requirements, and nothing on this site is offered against it.
GHK-Cu is one of the peptides listed in a Health Canada public advisory covering unauthorized injectable products sold online. The advisory addresses material sold for people to inject without authorization. Borealis Peptides supplies research material for in-vitro laboratory work and offers nothing for injection or for any use in a person, which is exactly the line the advisory draws.